Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
Troels Wienecke, Course Director of Clinical Course in Neurology and Neurosurgery at University of Copenhagen, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of the American Heart Association, adding:
“Would you like to connect the dots on Stroke and the JAK2V617F mutation?
The JAK2V617F is present in 11,3 percent of ischemic stroke patients and involved in thrombosis, inflammation, cancer and myeloproliferative disorders.
Have a look at the review from Marie Hvelplund Kristiansen.”
Title: JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke Neurology
Authors: Marie H. Kristiansen, Lasse Kjær, Vibe Skov, Morten K. Larsen, Christina Ellervik, Claus H. Nielsen, Hans C. Hasselbalch, Troels Wienecke
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements